What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2024-04-09 compared with 2023-03-31 · 44 added, 36 removed, 20 unchanged (80% of the section changed)

1 unchanged sentence

common stock is listed The Nasdaq Capital Market and its stock symbol is “HTCR.” The closing price of our common stock on

Nasdaq on March 30, 2023 was $1.00.

of March 31, 2023, there were 20,842,690 shares of common stock issued and outstanding, and we had approximately 56 holders of record

of our common stock.

Nasdaq on April 5, 2024 was $0.96.

of December 31, 2023, there were 20,842,690 shares of common stock issued and outstanding, and we had approximately 38 holders

of record of our common stock.

The number of record holders does not include beneficial owners of common stock whose shares are held

in the names of banks, brokers, nominees or other fiduciaries.

have not paid any cash dividends on our common stock and do not currently anticipate paying cash dividends in the foreseeable future.

We intend to retain future earnings, if any, for reinvestment in the development and expansion of our business.

have not paid any cash dividends on our common stock and we planned to pay dividends on May 3, 2024.

Authorized for Issuance Under Equity Compensation Plans

5 unchanged sentences

cash-based incentives for participants.

As of March 30, 2022, there were 6,330 shares authorized for issuance under

the 2021 Plan.

December 25, 2021, the Company awarded options to purchase 1,534,500 shares of common stock pursuant to our 2021 Plan

at an exercise price of $2.50 per share to various officers, directors, employees and consultants of the Company.

The options vest on

each annual anniversary of the date of issuance, in an amount equal to 25% of the applicable shares of common stock, subject to the terms

and conditions of the 2021 Plan and the option award agreements pursuant to which the options were awarded.

On February 9, 2022, the Company

entered into executive employment agreements with five executives and granted 85,820 restricted stock units pursuant to the 2021 Plan.

These common stock vest on each annual anniversary of the date of the employment agreement, in an amount equal to 25% of the applicable

shares of common shares.

August 2, 2022, the Company awarded options to purchase 2,000 shares of common stock pursuant to our 2021 Plan at an

exercise price of $2.94 per share to an employee.

The options vest on each annual anniversary of the date of issuance, in an amount

equal to 25% of the applicable shares of common stock, subject to the terms and conditions of the 2021 Plan and the

option award agreements pursuant to which the options were awarded.

As of December 31, 2023, there were 4,330 shares authorized for issuance under the 2021 Plan.

December 25, 2021, the Company awarded options to purchase 1,534,500 shares of common stock pursuant to our 2021 Plan at an exercise

price of $2.50 per share to various officers, directors, employees and consultants of the Company.

The options vest on each annual anniversary

of the date of issuance, in an amount equal to 25% of the applicable shares of common stock, subject to the terms and conditions of the

2021 Plan and the option award agreements pursuant to which the options were awarded.

February 9, 2022, the Company entered into executive employment agreements with five executives and granted 85,820 restricted stock units

pursuant to the 2021 Plan.

These common stock vest on each annual anniversary of the date of the employment agreement, in an amount equal

to 25% of the applicable shares of common shares.

August 2, 2022, the Company awarded options to purchase 2,000 shares of common stock pursuant to our 2021 Plan at an exercise price of

$2.94 per share to an employee.

The options vest on each annual anniversary of the date of issuance, in an amount equal to 25% of the

applicable shares of common stock, subject to the terms and conditions of the 2021 Plan and the option award agreements pursuant to which

the options were awarded.

February 3, 2023, the Company granted stock options to an employee to purchase 100,000 common shares at an exercise price of $1.17 per

1 unchanged sentence

The stock options will vest 50% on the grant date and February 1, 2024, respectively.

March 22, 2023, the Company granted 671,350 shares of common s hares to the employees and service providers of Sigmaways.

March 22, 2023, the Company granted 671,350 shares of common shares to the employees and service providers of Sigmaways.

August 1, 2023, the Board approved, and proposed for stockholder approval, the 2023 Equity Incentive Plan (the “2023 Plan”).

The shareholders approved the 2023 Plan at the Annual Shareholder’s meeting on September 29, 2023.

The 2023 Plan provides for various

stock-based incentive awards, including incentive stock options (“ISOs”) and non-qualified stock options (“NQSOs”),

stock appreciation rights (“SARs”), restricted stock and restricted stock units (“RSUs”), and other equity-based

or cash-based awards.

As of December 31, 2023, the Company has not granted any stock-based compensation awards to employees, including

officers, or non-employee directors pursuant to the 2023 Plan.

On August 25, 2023, the Company awarded options to purchase 2,000 shares

of common stock pursuant to our 2021 Plan at an exercise price of $1.10 per share to an employee.

The options vest on each annual anniversary

of the date of issuance, in an amount equal to 25% of the applicable shares of common stock, subject to the terms and conditions of the

2021 Plan and the option award agreements pursuant to which the options were awarded.

of Equity Securities by the Issuer

On June 1, 2022, the Board of

Directors approved a share repurchase program (“2022 Share Repurchase Program”),

pursuant to which the Company is authorized to repurchase up to $3.5 million of its outstanding common shares.

The timing and amount of

repurchases under the program are determined by the Company’s management based on its evaluation of market conditions and other

June 1, 2022, the Board of Directors approved a share repurchase program (“2022 Share

Repurchase Program”), pursuant to which the Company is authorized to repurchase up to $3.5 million of its outstanding common shares.

The timing and amount of repurchases under the program are determined by the Company’s management based on its evaluation of market

conditions and other factors.

This program has no set termination date and may be suspended or discontinued at any time.

During the period from June 1,

2022 through September 30, 2022, the Company repurchased 1,349,390 shares of common shares at an average price of $2.59 per share totaling

approximately $3.5 million (including commissions) under the 2022 Share Repurchase Program.

As of September 30, 2022, the Company has

used up the entire balance authorized under the 2022 Share Repurchase Program.

On October 18, 2022, the

Board of Directors approved to retire all the repurchased shares.

As of December 31, 2022, all of the 1,349,390 treasury shares have

been retired.

the period from June 1, 2022 through September 30, 2022, the Company repurchased 1,349,390 shares of common shares at an average price

of $2.59 per share totaling approximately $3.5 million (including commissions) under the 2022 Share Repurchase Program.

As of September

30, 2022, the Company has used up the entire balance authorized under the 2022 Share Repurchase Program.

October 18, 2022, the Board of Directors approved to retire all the repurchased shares.

As of December 31, 2022, all of the 1,349,390

treasury shares have been retired.

Agent and Registrar

3 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity